Vol.65 No.2 March 2017

An overview of antibacterial agents in Japan: past, present, and future

Morimasa Yagisawa

Jpn. J. Chemother. 65 (2): 149-167, 2017

A multicenter randomized controlled study on the efficacy of moxifloxacin and garenoxacin for the treatment of adult community-acquired pneumonia

Yoshifumi Imamura, Akitaka Tanaka, Masato Tashiro, Tomomi Saijo, Kazuko Yamamoto, Taiga Miyazaki, Misuzu Tsukamoto, Koichi Izumikawa, Katsunori Yanagihara, Hiroshi Mukae and Shigeru Kohno

Jpn. J. Chemother. 65 (2): 168-174, 2017

National survey of therapeutic drug monitoring (TDM) of antimicrobial drugs

Kazuaki Matsumoto, Rina Isoda, Yuko Kuroda, Yuta Yokoyama and Junko Kizu

Jpn. J. Chemother. 65 (2): 175-182, 2017

Safety and immunogenicity of Clostridium difficile toxoid vaccine in Japanese adults

Osamu Matsuoka, Dhaval M. Patel, Shin Sasaki, Hayato Oka, Toru Sasaki, Patricia J. Pietrobon, Thelma Laot, Alain Bouckenooghe, Josemund Menezes and Guy de Bruyn

Jpn. J. Chemother. 65 (2): 183-191, 2017

Investigation of medical economic effect of new oral antimicrobial agents on pediatric acute otitis media

Noboru Yamanaka and Tomokazu Oshiki

Jpn. J. Chemother. 65 (2): 192-205, 2017